Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma

BACKGROUND: We performed a pilot study using Trojan vaccines in patients with advanced squamous cell carcinoma of the head and neck (SCCHN). These vaccines are composed of HLA-I and HLA-II restricted melanoma antigen E (MAGE)-A3 or human papillomavirus (HPV)-16 derived peptides, joined by furin-clea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Voskens, Caroline J., Sewell, Duane, Hertzano, Ronna, DeSanto, Jennifer, Rollins, Sandra, Lee, Myounghee, Taylor, Rodney, Wolf, Jeffrey, Suntharalingam, Mohan, Gastman, Brian, Papadimitriou, John C., Lu, Changwan, Tan, Ming, Morales, Robert, Cullen, Kevin, Celis, Esteban, Mann, Dean, Strome, Scott E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3725741/
https://ncbi.nlm.nih.gov/pubmed/22287423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.22004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados